A rating of 95 puts Novavax, Inc. (NVAX) near the top of the Biotechnology industry according to InvestorsObserver. Novavax, Inc.'s score of 95 means it scores higher than 95% of stocks in the industry. Novavax, Inc. also received an overall rating of 80, putting it above 80% of all stocks. Biotechnology is ranked 29 out of the 148 industries.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Novavax, Inc. (NVAX) stock is up 7.19% while the S&P 500 is down -0.59% as of 10:42 AM on Thursday, Sep 3. NVAX is higher by $7.40 from the previous closing price of $102.90 on volume of 3,449,631 shares. Over the past year the S&P 500 has gained 21.17% while NVAX is higher by 1890.97%. NVAX lost -$2.75 per share the over the last 12 months.

Click Here to get the full Stock Score Report on Novavax, Inc. (NVAX) Stock.

Originally posted here:
Is Novavax, Inc. (NVAX) a Winner in the Biotechnology Industry? - InvestorsObserver